World Pharma Market Global Pharmaceutical Market to December 2003 Sales through pharmacies in thirteen leading markets for the year to December 2003 grew at 8% to $315.4 Billion. For full details of this months figures visit the IMS Retail Drug Monitor section of the main imshealth.com site. See also:   top corporations top products top therapy areas Plus, review of the world market 2003, 2002, 2001, 2000 and 1999

In the News News items and the related impact on the pharmaceutical industry: Antithrombotics – current market and future outlook Renal cancer – therapeutic approaches   Bioequivalent generics displace copies in Latin America   New active substances plateau in 2004   Osteoporosis - new options for bone loss   Looking to China and cancer as cost containment slows growth   Search the archive for previous articles.

Market Report Lipitor leads the way in 2003 - 18 March 2004   Other reports: US market share continues to expand   Healthcare reforms precede EU accession in Central & Eastern Europe Latin America lagging behind in health care provision Asian Markets to reach 30 billion by 2005 Search the archive for previous reports.

Drug News Weekly news from pharmaceutical R&D: entecavir - 5 April 2005   Bristol-Myers Squibb registered, USA (hepatitis B) oxycodone + ibuprofen - 30 March 2005   Forest marketed, USA (pain) HEXVIX - 16 March 2005   PhotoCure registered, EU (diagnosis) natalizumab - 8 March 2005   Biogen Idec, Elan suspended, Worldwide (multiple sclerosis, Crohn's disease, rheumatoid arthritis) duloxetine - 25 February 2005   Boehringer Ingelheim, Lilly recommended for approval, EU (neuropathic pain) abraxane - 18 February 2005   American Pharmaceutical Partners marketed, USA (breast cancer)     Search the archive for previous news.